Stereotaxis (NYSEMKT: STXS)
Stereotaxis Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Stereotaxis Company Info
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
News & Analysis
Valuation
Earnings Transcripts
Stereotaxis (STXS) Q2 2022 Earnings Call Transcript
STXS earnings call for the period ending June 30, 2022.
Stereotaxis (STXS) Q1 2022 Earnings Call Transcript
STXS earnings call for the period ending March 31, 2022.
Stereotaxis (STXS) Q3 2021 Earnings Call Transcript
STXS earnings call for the period ending September 30, 2021.
Stereotaxis (STXS) Q2 2021 Earnings Call Transcript
STXS earnings call for the period ending June 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.